Brief: Cantargia Says Oppositions Have Been Filed Against Co's Ep3293202 Patent

Cantargia AB

01/12/2021 15:02

Dec 1 (Reuters) - Cantargia AB  CANTA.ST :
    * REPORTED THAT OPPOSITIONS HAVE BEEN FILED AGAINST ONE OF CO'S EUROPEAN PATENTS, EP3293202
    * OPPOSITIONS HAVE NO FORMAL IMPACT ON CANTARGIA'S OTHER PATENTS, INCLUDING THOSE
SPECIFICALLY
COVERING NADUNOLIMAB
    * NEXT STEP IS A FORMAL PROCEDURE WHERE CANTARGIA IS INVITED TO COMMENT ON OPPOSITIONS
    * THIS PROCESS IS EXPECTED TO CONCLUDE WITHIN 1-2 YEARS.

Source text for Eikon:  ID:nWkr1jDxfg 
Further company coverage:  CANTA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))